GxP (Good Practices)

Good Practices (GxP) are the regulatory framework that defines how regulated companies (pharmaceutical, biotech, food and medical device manufacturers) must operate to guarantee that their products are safe, effective and of consistent quality. The acronym combines a "G" (Good), an "x" placeholder that stands for the regulated process, and a "P" (Practices). Depending on the "x", the standard changes: GMP (Manufacturing), GLP (Laboratory), GDP (Distribution), GCP (Clinical research) and GAMP (computerized systems).

In the pharmaceutical sector, GxP is not a recommendation: it is a legal requirement audited by agencies such as ANMAT in Argentina, the FDA in the United States and the EMA in Europe. The core principle is that quality is built into the process, not inspected at the end: every step must be documented, controlled and reconstructable in an audit.

The operational heart of GxP is data integrity and traceability. Every record must meet the ALCOA+ principle (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring and Available), so that any inspector can verify what was done, who did it and when.

What problem GxP solves

In an industry where a manufacturing error can affect the health of thousands of people, GxP exists so that quality is systematic and demonstrable, not a matter of luck or of an operator's judgment. The set of Good Practices turns intentions into written procedures, verifiable controls and documented evidence. When a batch of medicine goes to market, the company must be able to prove that every raw material, every piece of equipment and every signature met the standard. That ability to reconstruct the complete history of a product is what sets a regulated operation apart from one that is not.

The GxP families

The "x" placeholder groups several disciplines that cover the entire life cycle of a regulated product. Each has its own body of regulations, but they share the same philosophy of control and documentation.

• GMP (Good Manufacturing Practice): the best known. It regulates production, facilities, equipment, quality control and batch release. In Argentina, ANMAT requires it through Disposición 3602/2018 and its updates.
• GLP (Good Laboratory Practice): applies to nonclinical safety studies, ensuring that test data is reliable and reproducible.
• GDP (Good Distribution Practice): governs the supply chain, transportation and storage, with a focus on the cold chain for temperature-sensitive products.
• GCP (Good Clinical Practice): governs trials in humans, protecting patients' rights and the validity of the data.
• GAMP (Good Automated Manufacturing Practice): a framework for validating computerized systems, now key given the digitization of plants.

How GxP translates into day-to-day work

In practice, complying with GxP means operating on three pillars: written procedures (the SOPs that detail each task), complete records of everything executed, and validation of processes, equipment and systems. A computer system used in a plant, for example, is not "installed": it is validated (CSV, Computer System Validation) to show that it does what it claims to do, consistently. Every critical action leaves an auditable trail, which in digital systems is achieved with an electronic audit trail, valid signatures and access control. Digitized document classification and pharmaceutical traceability help make compliance native rather than an after-the-fact manual effort.

ALCOA+ versus manual compliance

A common confusion is thinking that having "a lot of documentation" equals GxP compliance. It does not: what matters is the integrity of that documentation. This table sums up the difference between a fragile manual approach and a robust digital one.

Common mistakes when implementing GxP

The most frequent mistake is treating GxP as a closing formality rather than a way of operating. Documenting after doing things violates the principle of contemporaneous recording: data must be captured at the moment, not reconstructed from memory. Another typical mistake is incomplete validation of computerized systems, which leaves gaps an inspector spots immediately. Finally, many organizations underestimate the integrity of electronic data: without an audit trail and access control, digital data is worth as little as an unsigned piece of paper.

Why it matters for business in Argentina

For an Argentine laboratory that wants to export, GxP is the key to entering regulated markets. A plant without GMP certification cannot sell to Brazil (Anvisa), the United States (FDA) or Europe (EMA). Beyond access, the cost of noncompliance is enormous: from a product recall to the suspension of the plant's license. That is why investing in processes that make compliance sustainable is a competitive advantage that reduces operational risk and speeds up audits.